We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QUAD:NYSEQuad Graphics, Inc Analysis

Data as of 2026-04-27 - not real-time

$7.89

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Quad/Graphics is trading at $7.89, comfortably above its 20‑day ($7.25), 50‑day ($6.94) and 200‑day ($6.28) moving averages, indicating a bullish technical backdrop. The stock’s RSI of 76.9 signals overbought conditions, while a bullish MACD (0.28 line vs 0.23 signal) and a tight support at $6.48 versus resistance near $7.96 suggest limited upside in the very short term. Valuation appears attractive: a trailing PE of 13.8 versus an industry average of 31.1, a forward PE of 5.9, and analyst price targets averaging $10 imply a potential upside of roughly 26%. The dividend yield remains high at 5.07% with a payout ratio near 52%, though the balance sheet is strained by a debt‑to‑equity ratio of 346% and cash of only $63 M against $445 M of debt.
The fundamentals show a revenue decline of 11% and thin margins (gross 21.6%, operating 3.7%, profit 1.1%), yet ROE is robust at 30% and free cash flow remains positive. Recent news of a temporary surcharge on inks and coatings aims to offset rising ink costs driven by Middle‑East supply‑chain disruptions, which should help protect margins. Analyst consensus is a “strong buy” with an “extreme greed” market sentiment, but the high leverage and 30‑day volatility of 23% elevate the overall risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicates overbought conditions
  • Price is near resistance at $7.96
  • Decreasing trading volume suggests waning momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to industry PE
  • High dividend yield with attractive forward earnings
  • Analyst consensus strong‑buy and 25% upside target

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated debt‑to‑equity ratio raises financial risk
  • Strong ROE and positive free cash flow support sustainability
  • Strategic surcharge may stabilize margins amid cost pressures

Key Metrics & Analysis

Financial Health

Revenue Growth-11.00%
Profit Margin1.12%
P/E Ratio13.8
ROE30.25%
ROA5.13%
Debt/Equity346.11
P/B Ratio3.1
Op. Cash Flow$95.9M
Free Cash Flow$13.2M
Industry P/E31.1

Technical Analysis

TrendBullish
RSI76.9
Support$6.48
Resistance$7.96
MA 20$7.25
MA 50$6.94
MA 200$6.28
MACDBullish
VolumeDecreasing
Fear & Greed Index88.02

Valuation

Target Price$9.93
Upside/Downside25.90%
GradeUndervalued
TypeValue
Dividend Yield5.07%

Risk Assessment

Beta0.99
Volatility23.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.